Personalized Predictions of Therapeutic Hypothermia Outcomes in Cardiac Arrest Patients with Shockable Rhythms Using Explainable Machine Learning

利用可解释机器学习对具有可电击心律的心脏骤停患者进行个性化低温治疗效果预测

阅读:1

Abstract

Background: Therapeutic hypothermia (TH) represents a critical therapeutic intervention for patients with cardiac arrest, although treatment efficacy and prognostic factors may vary between individuals. Precise, personalized outcome predictions can empower better clinical decisions. Methods: In this multi-center retrospective cohort study involving nine medical centers in Taiwan, we developed machine learning algorithms to predict neurological outcomes in patients who experienced cardiac arrest with shockable rhythms and underwent TH. The study cohort comprised 209 patients treated between January 2014 and September 2019. The models were trained on patients' pre-treatment characteristics collected during this study period. The optimal artificial neural network (ANN) model was interpretable using the SHapley Additive exPlanations (SHAP) method. Results: Among the 209 enrolled patients, 79 (37.80%) demonstrated favorable neurological outcomes at discharge. The ANN model achieved an area under the curve value of 0.9089 (accuracy = 0.8330, precision = 0.7984, recall = 0.7492, specificity = 0.8846) for outcome prediction. SHAP analysis identified vital predictive features, including the dose of epinephrine during resuscitation, diabetes status, body temperature at return of spontaneous circulation (ROSC), whether the cardiac arrest was witnessed, and diastolic blood pressure at ROSC. Using real-life case examples, we demonstrated how the ANN model provides personalized prognostic predictions tailored to individuals' distinct profiles. Conclusion: Our machine learning approach delivers personalized forecasts of TH outcomes in cardiac arrest patients with shockable rhythms. By accounting for each patient's unique health history and cardiac arrest event details, the ANN model empowers more precise risk stratification, tailoring clinical decision-making regarding TH prognostication and optimizing personalized treatment planning.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。